2014 Clinical Endocrinology Update

San Francisco, CA US
September 4, 2014 to September 6, 2014

Hilton San Francisco Union Square
San Francisco, California
September 4-6, 2014

Each year CEU brings together hundreds of endocrine clinicians for a unique learning experience and opportunities to network with expert faculty and colleagues. Attend the 66th Clinical Endocrinology Update (CEU) to receive the most trusted and clinically relevant information about recent advances in the field of endocrinology. The 2014 meeting will be held in San Francisco, CA, September 4-6, and is preceded by the Endocrine Board Review course with other workshops and events available during the week.

Target Audience

The educational programming at CEU appeals to clinicians at all levels of practice, as well as fellows and other members of the clinical practice team.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Discuss state-of-the-art research in endocrinology
  • Demonstrate updated knowledge of the diagnosis and treatment of diabetes, lipid, osteoporosis, pituitary, adrenal, thyroid, and reproductive endocrine disorders
  • Employ enhanced skills and practice management techniques to improve patient care

Additional Information

Target Audience: 
Clinical researcher
Scientific researcher
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Competency Area: 
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
Interpersonal and Communication Skills
Systems-based Practice
Topic Area: 
Adrenal/HPA Axis
Bone and Calciotropic Hormones
Diabetes and Glucose Metabolism
Lipid Disorders and Fatty Liver Diseases
Quality Improvement and Healthcare Delivery
General Endocrinology
Hormone Abuse
Growth Disorders
Health Disparities
Hormones and Cancer
Men’s Health
Neuroendocrinology and Pituitary
Pediatric Endocrinology
Thyroid/HPT Axis
Women’s Health
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 3B (Learning: Procedural Knowledge (Knows How))
Level 4 (Learning: Competence (Shows How))
Activity summary
Available credit: 
  • 25.25 AMA PRA Category 1 Credits
  • 25.25 CME Certificate of Participation
Course opens: 
Course expires: 
Event starts: 
09/04/2014 - 7:00am
Event ends: 
09/06/2014 - 7:00pm
Hilton San Francisco Union Square
333 O'Farrell Street
San Francisco, CA 94102
United States

Wiebke Arlt, MD, DSc; University of Birmingham (Birmingham, United Kingdom)
Rebecca S. Bahn, MD; Mayo Clinic (Rochester, MN)
Lynn A. Barbour, MD, MSPH; University of Colorado
Douglas C. Bauer, MD; University of California, San Francisco
Richard Bebb, MD; University of British Columbia (Vancouver, Canada)
Daniel H. Bessesen, MD; University of Colorado
Keith C. Bible, MD, PhD; Mayo Clinic (Rochester, MN)
Marc Cornier, MD; University of Colorado
Edward Damiano, PhD; Boston University
David A. Ehrmann, MD; The University of Chicago Medicine
Wylie C. Hembree, MD; New York Presbyterian Hospital/Columbia University
Irl B. Hirsch, MD; University of Washington
Sophie Jamal, MD, PhD; University of Toronto (Toronto, Canada)
Peter H. Jones, MD; Baylor College of Medicine
Steven E. Kahn, MB ChB; University of Washington
Laurence Katznelson, MD; Stanford University
Susan J. Mandel, MD, MPH; University of Pennsylvania
Kathryn A. Martin, MD; Massachusetts General Hospital
Michael R. McClung, MD; Oregon Osteoporosis Center
Eric S. Orwoll, MD; Oregon Health & Science University
Anne L. Peters, MD; University of Southern California
Anne L. Schafer, MD; University of California, San Francisco
Elizabeth R. Seaquist, MD; University of Minnesota
Dolores M. Shoback, MD; University of California, San Francisco
Alex S. Stagnaro-Green, MD; George Washington University
Cynthia A. Stuenkel, MD; University of California, San Diego
Peter J. Trainer, MD, MB ChB, BSc; The Christie Hospital (Manchester, United Kingdom)
Anand Vaidya, MD, MMSc ; Brigham and Women’s Hospital
Aaron I. Vinik, MD, PhD; Eastern Virginia Medical School


Disclosure Policy

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported relevant financial relationships:

Richard Bebb, MD: Advisory Board Member and Speaker, Abbott, Bayer, Lilly
David Cooper, MD: Editor, UpToDate
Daniel H. Bessesen, MD: DSMB Member, Enteromedics
David A. Ehrmann, MD: Consultant, AstraZeneca
Irl B. Hirsch, MD: Consultant, Abbott, BD, Roche; Investigator, Sanofi, Halozyme; 
Peter H. Jones, MD:  Advisory Board Member, Amarin, Atherotech, Daiichi Sankyo and Merck
Steven E. Kahn, MB ChB: Consultant, Boehringer Ingelheim, Elcelyx, GlaxoSmithKline, Intarcia, Kanssen; Consultant and Research Grant Support, Eli Lilly, 
Kathryn A. Martin, MD: Employee and Editor, UpToDate
Michael R. McClung, MD: Consultant and Speaker, Amgen and Merck; Consultant, Lilly 
Eric S. Orwoll, MD: Advisory Board, UCB Biosciences; Advisory Board and Investigator, Merck, Lilly 
Anne L. Peters, MD: Consultant, Eli Lilly, Sanofi, Medtronic, BD; Consultant and Speaker, AstraZeneca, Novo Nordisk
Elizabeth R. Seaquist, MD: Consultant, Bristol-Myers Squibb, SkyePHarma; Consultant and Investigator, AMG Medical; Investigator, Lilly
Cynthia A. Stuenkel, MD: Consultant, Ligand, Pharmavite, Pfizer
Peter J. Trainer, MD, MB ChB, BSc: Advisory Board, Versaitis, Roche; Advisory Board and Invesigator, Novartis; Investigator, Chaisma
Anand Vaidya, MD, MMSc: Advisory Board Member, Corcept Therapeutics
Aaron I. Vinik, MD, PhD:  Consultant, ISIS Pharmaceuticals and Pfizer; Consultant and Speaker, Merck

The following faculty reported no relevant financial relationships: Wiebke Arlt, MD, DSc; Rebecca S. Bahn, MD; Lynn A. Barbour, MD, MSPH; Douglas C. Bauer, MD; Keith C. Bible, MD, PhD; Marc Cornier, MD; Edward Damiano, PhD; Wylie C. Hembree, MD; Sophie Jamal, MD, PhD; Laurence Katznelson, MD; Susan J. Mandel, MD, MPH; Anne L. Schafer, MD; Elizabeth R. Seaquist, MD; Dolores M. Shoback, MD; Alex S. Stagnaro-Green, MD

The following Clinical Endocrinology Update Steering Committee members who planned and/or reviewed content for this activity reported relevant financial relationships: 

Susan A. Sherman, MD: Stock, BMS, HCA, ARCA Pharma; Spouse: Speaker, AstraZeneca
Robert C. Smallridge, MD: Principal Investigator, Novo Nordisk

The following Clinical Endocrinology Update Steering Committee members who planned and/or reviewed content for this activity reported no relevant financial relationships: Carlos A. Aguilar Salinas, MD; Carolyn B. Becker, MD; Richard S. Bockman, MD; Ann Danoff, MD; Sabrina Gill, MD, MPH; Ariel Sánchez, MD, PhD; Nalini Shah, DM.

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

Available Credit

  • 25.25 AMA PRA Category 1 Credits
  • 25.25 CME Certificate of Participation